These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 23867982)
61. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia. Meltzer HY; McGurk SR Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729 [TBL] [Abstract][Full Text] [Related]
62. Effects of chronic ketamine use on frontal and medial temporal cognition. Chan KW; Lee TM; Siu AM; Wong DP; Kam CM; Tsang SK; Chan CC Addict Behav; 2013 May; 38(5):2128-32. PubMed ID: 23435274 [TBL] [Abstract][Full Text] [Related]
63. The interaction between medical burden and anticholinergic cognitive burden on neuropsychological function in a geriatric primary care sample. Block CK; Logue E; Thaler NS; Scarisbrick DM; Mahoney JJ; Scott J; Duff K Arch Clin Neuropsychol; 2015 Mar; 30(2):105-13. PubMed ID: 25549761 [TBL] [Abstract][Full Text] [Related]
65. Histamine H1-receptor blockade in humans affects psychomotor performance but not memory. van Ruitenbeek P; Vermeeren A; Riedel W J Psychopharmacol; 2008 Aug; 22(6):663-72. PubMed ID: 18208925 [TBL] [Abstract][Full Text] [Related]
66. The effects of daidzin and its aglycon, daidzein, on the scopolamine-induced memory impairment in male mice. Kim DH; Jung HA; Park SJ; Kim JM; Lee S; Choi JS; Cheong JH; Ko KH; Ryu JH Arch Pharm Res; 2010 Oct; 33(10):1685-90. PubMed ID: 21052945 [TBL] [Abstract][Full Text] [Related]
67. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism. Oertel H; Schneider HJ; Stalla GK; Holsboer F; Zihl J Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699 [TBL] [Abstract][Full Text] [Related]
68. Cognitive function in association with sex hormones in postmenopausal women. Kocoska-Maras L; Rådestad AF; Carlström K; Bäckström T; von Schoultz B; Hirschberg AL Gynecol Endocrinol; 2013 Jan; 29(1):59-62. PubMed ID: 22967437 [TBL] [Abstract][Full Text] [Related]
69. Memory enhancement by Tamoxifen on amyloidosis mouse model. Pandey D; Banerjee S; Basu M; Mishra N Horm Behav; 2016 Mar; 79():70-3. PubMed ID: 26435474 [TBL] [Abstract][Full Text] [Related]
70. Increased anticholinergic challenge-induced memory impairment associated with the APOE-epsilon4 allele in the elderly: a controlled pilot study. Pomara N; Willoughby LM; Wesnes K; Sidtis JJ Neuropsychopharmacology; 2004 Feb; 29(2):403-9. PubMed ID: 14735126 [TBL] [Abstract][Full Text] [Related]
71. A comparison of scopolamine and biperiden as a rodent model for cholinergic cognitive impairment. Klinkenberg I; Blokland A Psychopharmacology (Berl); 2011 Jun; 215(3):549-66. PubMed ID: 21336581 [TBL] [Abstract][Full Text] [Related]
72. Systemic sulpiride in young adult volunteers simulates the profile of cognitive deficits in Parkinson's disease. Mehta MA; Sahakian BJ; McKenna PJ; Robbins TW Psychopharmacology (Berl); 1999 Sep; 146(2):162-74. PubMed ID: 10525751 [TBL] [Abstract][Full Text] [Related]
73. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. Gleason CE; Dowling NM; Wharton W; Manson JE; Miller VM; Atwood CS; Brinton EA; Cedars MI; Lobo RA; Merriam GR; Neal-Perry G; Santoro NF; Taylor HS; Black DM; Budoff MJ; Hodis HN; Naftolin F; Harman SM; Asthana S PLoS Med; 2015 Jun; 12(6):e1001833; discussion e1001833. PubMed ID: 26035291 [TBL] [Abstract][Full Text] [Related]
74. Increased cognitive sensitivity to scopolamine with age and a perspective on the scopolamine model. Molchan SE; Martinez RA; Hill JL; Weingartner HJ; Thompson K; Vitiello B; Sunderland T Brain Res Brain Res Rev; 1992; 17(3):215-26. PubMed ID: 1467811 [TBL] [Abstract][Full Text] [Related]
75. Increased memory load-related frontal activation after estradiol treatment in postmenopausal women. Dumas JA; Kutz AM; Naylor MR; Johnson JV; Newhouse PA Horm Behav; 2010 Nov; 58(5):929-35. PubMed ID: 20849856 [TBL] [Abstract][Full Text] [Related]
76. Verified hormone therapy improves episodic memory performance in healthy postmenopausal women. Yonker JE; Adolfsson R; Eriksson E; Hellstrand M; Nilsson LG; Herlitz A Neuropsychol Dev Cogn B Aging Neuropsychol Cogn; 2006; 13(3-4):291-307. PubMed ID: 16887775 [TBL] [Abstract][Full Text] [Related]
77. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Joffe H; Hall JE; Gruber S; Sarmiento IA; Cohen LS; Yurgelun-Todd D; Martin KA Menopause; 2006; 13(3):411-22. PubMed ID: 16735938 [TBL] [Abstract][Full Text] [Related]
78. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Schilder CM; Eggens PC; Seynaeve C; Linn SC; Boogerd W; Gundy CM; Beex LV; Van Dam FS; Schagen SB Acta Oncol; 2009; 48(1):76-85. PubMed ID: 18777410 [TBL] [Abstract][Full Text] [Related]
79. Cognitive dysfunctions induced by a cholinergic blockade and Aβ 25-35 peptide are attenuated by salvianolic acid B. Kim DH; Park SJ; Kim JM; Jeon SJ; Kim DH; Cho YW; Son KH; Lee HJ; Moon JH; Cheong JH; Ko KH; Ryu JH Neuropharmacology; 2011 Dec; 61(8):1432-40. PubMed ID: 21903108 [TBL] [Abstract][Full Text] [Related]